Oct 17, 2017 Cellectar Biosciences Receives Additional Japanese Patent for CLR 131 and CLR 125 for the Treatment of Various Solid Tumors Learn More
Oct 12, 2017 Cellectar Biosciences Announces Successful Completion of $7.76 Million Registered Direct Offering Learn More
Oct 10, 2017 Cellectar Biosciences Announces $7.76 Million Registered Direct Offering Priced At-The-Market Learn More
Oct 10, 2017 Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates Learn More